A Phase I Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Carfilzomib (Primary) ; Panobinostat (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- 20 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 01 Dec 2016 Planned End Date changed from 1 Aug 2016 to 1 Dec 2017.
- 07 Oct 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Aug 2016 as reported by ClinicalTrials.gov record.